img

Global Solid Tumor Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Solid Tumor Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Solid Tumor Drug Market
Global Solid Tumor Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Solid Tumor Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Solid Tumor Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Solid Tumor Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


AstraZeneca
Biogen
Baxter
Celgene Corporation
Abbott Laboratories
Pfizer Inc
Amgen Limited & Amgen Ireland Limited
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Johnson & Johnson
Segment by Type
Small Molecules
Biologics

Segment by Application


Oncology
Neurology
Radiology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Solid Tumor Drug introduction, etc. Solid Tumor Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Solid Tumor Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Tumor Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Solid Tumor Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Neurology
1.3.4 Radiology
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Tumor Drug Market Perspective (2018-2029)
2.2 Global Solid Tumor Drug Growth Trends by Region
2.2.1 Solid Tumor Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Solid Tumor Drug Historic Market Size by Region (2018-2024)
2.2.3 Solid Tumor Drug Forecasted Market Size by Region (2024-2029)
2.3 Solid Tumor Drug Market Dynamics
2.3.1 Solid Tumor Drug Industry Trends
2.3.2 Solid Tumor Drug Market Drivers
2.3.3 Solid Tumor Drug Market Challenges
2.3.4 Solid Tumor Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Solid Tumor Drug by Players
3.1.1 Global Solid Tumor Drug Revenue by Players (2018-2024)
3.1.2 Global Solid Tumor Drug Revenue Market Share by Players (2018-2024)
3.2 Global Solid Tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Solid Tumor Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Solid Tumor Drug Market Concentration Ratio
3.4.1 Global Solid Tumor Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Tumor Drug Revenue in 2022
3.5 Global Key Players of Solid Tumor Drug Head office and Area Served
3.6 Global Key Players of Solid Tumor Drug, Product and Application
3.7 Global Key Players of Solid Tumor Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Tumor Drug Breakdown Data by Type
4.1 Global Solid Tumor Drug Historic Market Size by Type (2018-2024)
4.2 Global Solid Tumor Drug Forecasted Market Size by Type (2024-2029)
5 Solid Tumor Drug Breakdown Data by Application
5.1 Global Solid Tumor Drug Historic Market Size by Application (2018-2024)
5.2 Global Solid Tumor Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Solid Tumor Drug Market Size (2018-2029)
6.2 North America Solid Tumor Drug Market Size by Type
6.2.1 North America Solid Tumor Drug Market Size by Type (2018-2024)
6.2.2 North America Solid Tumor Drug Market Size by Type (2024-2029)
6.2.3 North America Solid Tumor Drug Market Share by Type (2018-2029)
6.3 North America Solid Tumor Drug Market Size by Application
6.3.1 North America Solid Tumor Drug Market Size by Application (2018-2024)
6.3.2 North America Solid Tumor Drug Market Size by Application (2024-2029)
6.3.3 North America Solid Tumor Drug Market Share by Application (2018-2029)
6.4 North America Solid Tumor Drug Market Size by Country
6.4.1 North America Solid Tumor Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Solid Tumor Drug Market Size by Country (2018-2024)
6.4.3 North America Solid Tumor Drug Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Solid Tumor Drug Market Size (2018-2029)
7.2 Europe Solid Tumor Drug Market Size by Type
7.2.1 Europe Solid Tumor Drug Market Size by Type (2018-2024)
7.2.2 Europe Solid Tumor Drug Market Size by Type (2024-2029)
7.2.3 Europe Solid Tumor Drug Market Share by Type (2018-2029)
7.3 Europe Solid Tumor Drug Market Size by Application
7.3.1 Europe Solid Tumor Drug Market Size by Application (2018-2024)
7.3.2 Europe Solid Tumor Drug Market Size by Application (2024-2029)
7.3.3 Europe Solid Tumor Drug Market Share by Application (2018-2029)
7.4 Europe Solid Tumor Drug Market Size by Country
7.4.1 Europe Solid Tumor Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Solid Tumor Drug Market Size by Country (2018-2024)
7.4.3 Europe Solid Tumor Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Solid Tumor Drug Market Size (2018-2029)
8.2 China Solid Tumor Drug Market Size by Type
8.2.1 China Solid Tumor Drug Market Size by Type (2018-2024)
8.2.2 China Solid Tumor Drug Market Size by Type (2024-2029)
8.2.3 China Solid Tumor Drug Market Share by Type (2018-2029)
8.3 China Solid Tumor Drug Market Size by Application
8.3.1 China Solid Tumor Drug Market Size by Application (2018-2024)
8.3.2 China Solid Tumor Drug Market Size by Application (2024-2029)
8.3.3 China Solid Tumor Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Solid Tumor Drug Market Size (2018-2029)
9.2 Asia Solid Tumor Drug Market Size by Type
9.2.1 Asia Solid Tumor Drug Market Size by Type (2018-2024)
9.2.2 Asia Solid Tumor Drug Market Size by Type (2024-2029)
9.2.3 Asia Solid Tumor Drug Market Share by Type (2018-2029)
9.3 Asia Solid Tumor Drug Market Size by Application
9.3.1 Asia Solid Tumor Drug Market Size by Application (2018-2024)
9.3.2 Asia Solid Tumor Drug Market Size by Application (2024-2029)
9.3.3 Asia Solid Tumor Drug Market Share by Application (2018-2029)
9.4 Asia Solid Tumor Drug Market Size by Region
9.4.1 Asia Solid Tumor Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Solid Tumor Drug Market Size by Region (2018-2024)
9.4.3 Asia Solid Tumor Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Solid Tumor Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Solid Tumor Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Solid Tumor Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Solid Tumor Drug Introduction
11.1.4 AstraZeneca Revenue in Solid Tumor Drug Business (2018-2024)
11.1.5 AstraZeneca Recent Developments
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Solid Tumor Drug Introduction
11.2.4 Biogen Revenue in Solid Tumor Drug Business (2018-2024)
11.2.5 Biogen Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Solid Tumor Drug Introduction
11.3.4 Baxter Revenue in Solid Tumor Drug Business (2018-2024)
11.3.5 Baxter Recent Developments
11.4 Celgene Corporation
11.4.1 Celgene Corporation Company Details
11.4.2 Celgene Corporation Business Overview
11.4.3 Celgene Corporation Solid Tumor Drug Introduction
11.4.4 Celgene Corporation Revenue in Solid Tumor Drug Business (2018-2024)
11.4.5 Celgene Corporation Recent Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Solid Tumor Drug Introduction
11.5.4 Abbott Laboratories Revenue in Solid Tumor Drug Business (2018-2024)
11.5.5 Abbott Laboratories Recent Developments
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Solid Tumor Drug Introduction
11.6.4 Pfizer Inc Revenue in Solid Tumor Drug Business (2018-2024)
11.6.5 Pfizer Inc Recent Developments
11.7 Amgen Limited & Amgen Ireland Limited
11.7.1 Amgen Limited & Amgen Ireland Limited Company Details
11.7.2 Amgen Limited & Amgen Ireland Limited Business Overview
11.7.3 Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Introduction
11.7.4 Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2018-2024)
11.7.5 Amgen Limited & Amgen Ireland Limited Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Company Details
11.8.2 Bristol-Myers Squibb Company Business Overview
11.8.3 Bristol-Myers Squibb Company Solid Tumor Drug Introduction
11.8.4 Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2018-2024)
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 GlaxoSmithKline plc.
11.9.1 GlaxoSmithKline plc. Company Details
11.9.2 GlaxoSmithKline plc. Business Overview
11.9.3 GlaxoSmithKline plc. Solid Tumor Drug Introduction
11.9.4 GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2018-2024)
11.9.5 GlaxoSmithKline plc. Recent Developments
11.10 F. Hoffmann-La Roche Ltd.
11.10.1 F. Hoffmann-La Roche Ltd. Company Details
11.10.2 F. Hoffmann-La Roche Ltd. Business Overview
11.10.3 F. Hoffmann-La Roche Ltd. Solid Tumor Drug Introduction
11.10.4 F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2018-2024)
11.10.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Details
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Solid Tumor Drug Introduction
11.11.4 Eli Lilly and Company Revenue in Solid Tumor Drug Business (2018-2024)
11.11.5 Eli Lilly and Company Recent Developments
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Solid Tumor Drug Introduction
11.12.4 Johnson & Johnson Revenue in Solid Tumor Drug Business (2018-2024)
11.12.5 Johnson & Johnson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Solid Tumor Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global Solid Tumor Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Solid Tumor Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Solid Tumor Drug Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Solid Tumor Drug Market Share by Region (2018-2024)
Table 8. Global Solid Tumor Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Solid Tumor Drug Market Share by Region (2024-2029)
Table 10. Solid Tumor Drug Market Trends
Table 11. Solid Tumor Drug Market Drivers
Table 12. Solid Tumor Drug Market Challenges
Table 13. Solid Tumor Drug Market Restraints
Table 14. Global Solid Tumor Drug Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Solid Tumor Drug Revenue Share by Players (2018-2024)
Table 16. Global Top Solid Tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)
Table 17. Global Solid Tumor Drug Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Solid Tumor Drug Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Solid Tumor Drug, Headquarters and Area Served
Table 20. Global Key Players of Solid Tumor Drug, Product and Application
Table 21. Global Key Players of Solid Tumor Drug, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Solid Tumor Drug Revenue Market Share by Type (2018-2024)
Table 25. Global Solid Tumor Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Solid Tumor Drug Revenue Market Share by Type (2024-2029)
Table 27. Global Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Solid Tumor Drug Revenue Share by Application (2018-2024)
Table 29. Global Solid Tumor Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Solid Tumor Drug Revenue Share by Application (2024-2029)
Table 31. North America Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Solid Tumor Drug Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Solid Tumor Drug Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Solid Tumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Solid Tumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Solid Tumor Drug Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Solid Tumor Drug Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Solid Tumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Solid Tumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Solid Tumor Drug Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Solid Tumor Drug Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Solid Tumor Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Solid Tumor Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Solid Tumor Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Solid Tumor Drug Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Solid Tumor Drug Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Solid Tumor Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Solid Tumor Drug Market Size by Country (2024-2029) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Solid Tumor Drug Product
Table 66. AstraZeneca Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 67. AstraZeneca Recent Developments
Table 68. Biogen Company Details
Table 69. Biogen Business Overview
Table 70. Biogen Solid Tumor Drug Product
Table 71. Biogen Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 72. Biogen Recent Developments
Table 73. Baxter Company Details
Table 74. Baxter Business Overview
Table 75. Baxter Solid Tumor Drug Product
Table 76. Baxter Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 77. Baxter Recent Developments
Table 78. Celgene Corporation Company Details
Table 79. Celgene Corporation Business Overview
Table 80. Celgene Corporation Solid Tumor Drug Product
Table 81. Celgene Corporation Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 82. Celgene Corporation Recent Developments
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Solid Tumor Drug Product
Table 86. Abbott Laboratories Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 87. Abbott Laboratories Recent Developments
Table 88. Pfizer Inc Company Details
Table 89. Pfizer Inc Business Overview
Table 90. Pfizer Inc Solid Tumor Drug Product
Table 91. Pfizer Inc Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 92. Pfizer Inc Recent Developments
Table 93. Amgen Limited & Amgen Ireland Limited Company Details
Table 94. Amgen Limited & Amgen Ireland Limited Business Overview
Table 95. Amgen Limited & Amgen Ireland Limited Solid Tumor Drug Product
Table 96. Amgen Limited & Amgen Ireland Limited Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 97. Amgen Limited & Amgen Ireland Limited Recent Developments
Table 98. Bristol-Myers Squibb Company Company Details
Table 99. Bristol-Myers Squibb Company Business Overview
Table 100. Bristol-Myers Squibb Company Solid Tumor Drug Product
Table 101. Bristol-Myers Squibb Company Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 102. Bristol-Myers Squibb Company Recent Developments
Table 103. GlaxoSmithKline plc. Company Details
Table 104. GlaxoSmithKline plc. Business Overview
Table 105. GlaxoSmithKline plc. Solid Tumor Drug Product
Table 106. GlaxoSmithKline plc. Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 107. GlaxoSmithKline plc. Recent Developments
Table 108. F. Hoffmann-La Roche Ltd. Company Details
Table 109. F. Hoffmann-La Roche Ltd. Business Overview
Table 110. F. Hoffmann-La Roche Ltd. Solid Tumor Drug Product
Table 111. F. Hoffmann-La Roche Ltd. Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 112. F. Hoffmann-La Roche Ltd. Recent Developments
Table 113. Eli Lilly and Company Company Details
Table 114. Eli Lilly and Company Business Overview
Table 115. Eli Lilly and Company Solid Tumor Drug Product
Table 116. Eli Lilly and Company Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 117. Eli Lilly and Company Recent Developments
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Solid Tumor Drug Product
Table 121. Johnson & Johnson Revenue in Solid Tumor Drug Business (2018-2024) & (US$ Million)
Table 122. Johnson & Johnson Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Solid Tumor Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Solid Tumor Drug Market Share by Type: 2022 VS 2029
Figure 3. Small Molecules Features
Figure 4. Biologics Features
Figure 5. Global Solid Tumor Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Solid Tumor Drug Market Share by Application: 2022 VS 2029
Figure 7. Oncology Case Studies
Figure 8. Neurology Case Studies
Figure 9. Radiology Case Studies
Figure 10. Others Case Studies
Figure 11. Solid Tumor Drug Report Years Considered
Figure 12. Global Solid Tumor Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Solid Tumor Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Solid Tumor Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Solid Tumor Drug Market Share by Players in 2022
Figure 16. Global Top Solid Tumor Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Tumor Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Solid Tumor Drug Revenue in 2022
Figure 18. North America Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Solid Tumor Drug Market Share by Type (2018-2029)
Figure 20. North America Solid Tumor Drug Market Share by Application (2018-2029)
Figure 21. North America Solid Tumor Drug Market Share by Country (2018-2029)
Figure 22. United States Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Solid Tumor Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Solid Tumor Drug Market Share by Type (2018-2029)
Figure 26. Europe Solid Tumor Drug Market Share by Application (2018-2029)
Figure 27. Europe Solid Tumor Drug Market Share by Country (2018-2029)
Figure 28. Germany Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Solid Tumor Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Solid Tumor Drug Market Share by Type (2018-2029)
Figure 36. China Solid Tumor Drug Market Share by Application (2018-2029)
Figure 37. Asia Solid Tumor Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Solid Tumor Drug Market Share by Type (2018-2029)
Figure 39. Asia Solid Tumor Drug Market Share by Application (2018-2029)
Figure 40. Asia Solid Tumor Drug Market Share by Region (2018-2029)
Figure 41. Japan Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Solid Tumor Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Solid Tumor Drug Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Solid Tumor Drug Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Solid Tumor Drug Market Share by Country (2018-2029)
Figure 51. Brazil Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Solid Tumor Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 58. Biogen Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 59. Baxter Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 60. Celgene Corporation Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 61. Abbott Laboratories Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 62. Pfizer Inc Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 63. Amgen Limited & Amgen Ireland Limited Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 64. Bristol-Myers Squibb Company Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 65. GlaxoSmithKline plc. Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 66. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 67. Eli Lilly and Company Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 68. Johnson & Johnson Revenue Growth Rate in Solid Tumor Drug Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries